VA BENEFITS REFERENCE
DC 5012: Bones, Neoplasm, Malignant, Primary Or Secondary
Read VA diagnostic code 5012 for Bones, neoplasm, malignant, primary or secondary: published criteria, regulatory notes, related codes and official sources checked October 25, 2026.
Published criteria from 38 CFR 4.71a, current through 2026-10-22. Historical decisions may require a different version. This reference does not diagnose a condition or determine an evaluation.
The Musculoskeletal System · All Diagnostic Codes
DC 5012: Bones, Neoplasm, Malignant, Primary Or Secondary
Diagnostic code 5012 addresses Bones, neoplasm, malignant, primary or secondary. Read its specific instructions together with any shared formula, notes and linked provisions. These criteria describe evaluation after the applicable entitlement requirements are met; this reference does not diagnose a condition or determine a claim.
| Rating | |
|---|---|
| 5012 Bones, neoplasm, malignant, primary or secondary | 100 |
| Note: The 100 percent rating will be continued for 1 year following the cessation of surgical, X-ray, antineoplastic chemotherapy or other prescribed therapeutic procedure. If there has been no local recurrence or metastases, rate based on residuals. |
What The Criteria Measure
- Does the decision identify diagnostic code 5012, and does the medical record describe the condition named by this code?
- Do records identify the treatment, procedure and relevant dates that the provision actually distinguishes?
- Have the code-specific notes and cross-references been read before comparing any listed evaluation?
No public condition DBQ is mapped to this code. Consult the official public DBQ list and examination instructions.
Shared Rules And Regulatory Context
- 38 CFR 4.71a Context And Notes
- 38 CFR 4.40 Context And Notes
- 38 CFR 4.41 Context And Notes
- 38 CFR 4.42 Context And Notes
- 38 CFR 4.43 Context And Notes
- 38 CFR 4.44 Context And Notes
- 38 CFR 4.45 Context And Notes
- 38 CFR 4.46 Context And Notes
- 38 CFR 4.57 Context And Notes
- 38 CFR 4.58 Context And Notes
- 38 CFR 4.59 Context And Notes
- 38 CFR 4.61 Context And Notes
- 38 CFR 4.62 Context And Notes
- 38 CFR 4.63 Context And Notes
- 38 CFR 4.64 Context And Notes
- 38 CFR 4.66 Context And Notes
- 38 CFR 4.67 Context And Notes
- 38 CFR 4.68 Context And Notes
- 38 CFR 4.69 Context And Notes
- 38 CFR 4.70 Context And Notes
- 38 CFR 4.71 Context And Notes
Context provisions do not create an additional evaluation automatically assigned to every condition.
Related Guides
Official Sources
Last verified 2026-10-25. Source publication or legal effective dates are shown separately where available.
- www.ecfr.gov/current/title-38/chapter-I/part-4/section-4.71a
- www.ecfr.gov/current/title-38/chapter-I/part-4/section-4.40
- www.ecfr.gov/current/title-38/chapter-I/part-4/section-4.41
- www.ecfr.gov/current/title-38/chapter-I/part-4/section-4.42
- www.ecfr.gov/current/title-38/chapter-I/part-4/section-4.43
- www.ecfr.gov/current/title-38/chapter-I/part-4/section-4.44
- www.ecfr.gov/current/title-38/chapter-I/part-4/section-4.45
- www.ecfr.gov/current/title-38/chapter-I/part-4/section-4.46
- www.ecfr.gov/current/title-38/chapter-I/part-4/section-4.57
- www.ecfr.gov/current/title-38/chapter-I/part-4/section-4.58
- www.ecfr.gov/current/title-38/chapter-I/part-4/section-4.59
- www.ecfr.gov/current/title-38/chapter-I/part-4/section-4.61
- www.ecfr.gov/current/title-38/chapter-I/part-4/section-4.62
- www.ecfr.gov/current/title-38/chapter-I/part-4/section-4.63
- www.ecfr.gov/current/title-38/chapter-I/part-4/section-4.64
- www.ecfr.gov/current/title-38/chapter-I/part-4/section-4.66
- www.ecfr.gov/current/title-38/chapter-I/part-4/section-4.67
- www.ecfr.gov/current/title-38/chapter-I/part-4/section-4.68
- www.ecfr.gov/current/title-38/chapter-I/part-4/section-4.69
- www.ecfr.gov/current/title-38/chapter-I/part-4/section-4.70
- www.ecfr.gov/current/title-38/chapter-I/part-4/section-4.71
Check The Source. Get Accredited Help.
Use this resource to understand published information. VA and the official decision control individual benefits.